Genetic markers associated with early cancer-specific mortality following prostatectomy

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy

(2012) Gaetano Zafarana et al.   CANCER

Validating the Interval to Biochemical Failure for the Identification of Potentially Lethal Prostate Cancer

(2012) Mark K. Buyyounouski et al.   JOURNAL OF CLINICAL ONCOLOGY

Survival Among Men With Clinically Localized Prostate Cancer Treated With Radical Prostatectomy or Radiation Therapy in the Prostate Specific Antigen Era

(2012) Adam S. Kibel et al.   JOURNAL OF UROLOGY

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

(2012) Christopher E Barbieri et al.   NATURE GENETICS

Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer

(2011) Stephen A. Boorjian et al.   CANCER

Adjuvant Androgen Deprivation for High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921 Study

(2011) Tanya B. Dorff et al.   JOURNAL OF CLINICAL ONCOLOGY

SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression

(2011) Zhihu Ding et al.   NATURE

The genomic complexity of primary human prostate cancer

(2011) Michael F. Berger et al.   NATURE

Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer

(2011) Anna Bill-Axelson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Integrative Genomic Profiling of Human Prostate Cancer

(2010) Barry S. Taylor et al.   CANCER CELL

Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

(2009) Brett S Carver et al.   NATURE GENETICS

Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer

(2009) Wennuan Liu et al.   NATURE MEDICINE

Interactions between Cells with Distinct Mutations in c-MYC and Pten in Prostate Cancer

(2009) Jongchan Kim et al.   PLoS Genetics

Gene Panel Model Predictive of Outcome in Men at High-Risk of Systemic Progression and Death From Prostate Cancer After Radical Retropubic Prostatectomy

(2008) John C. Cheville et al.   JOURNAL OF CLINICAL ONCOLOGY

Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1

(2008) J. Zhu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Veterans Affairs Cooperative Studies Program Study 553: Chemotherapy After Prostatectomy, a Phase III Randomized Study of Prostatectomy Versus Prostatectomy with Adjuvant Docetaxel for Patients with High-Risk, Localized Prostate Cancer

(2008) Bruce Montgomery et al.   UROLOGY